Cargando…
A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults
INTRODUCTION: Hospitalized patients are often unable to ingest or tolerate oral antipyretics and recently an aqueous formulation of intravenous (IV) ibuprofen was approved by the US-FDA for the reduction of fever in adults. METHODS: We evaluated IV ibuprofen to reduce fever exceeding 101.0°F, measur...
Autores principales: | Morris, Peter E, Promes, John T, Guntupalli, Kalpalatha K, Wright, Patrick E, Arons, Murray M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911773/ https://www.ncbi.nlm.nih.gov/pubmed/20591173 http://dx.doi.org/10.1186/cc9089 |
Ejemplares similares
-
Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018) -
Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009) -
Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022) -
Intravenous levetiracetam in critically ill children
por: Incecik, Faruk, et al.
Publicado: (2016) -
Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)